From: Health-related quality of life following minimally invasive totally endoscopic mitral valve surgery
Item | EA group | SA group | P |
---|---|---|---|
Structural Valve Deterioration | 0 | 0 | NS |
Nonstructural Dysfunction | 0 | 0 | NS |
Valve Thrombosis | 0 | 0 | NS |
Embolism | 1 | 0 | NS |
Bleeding Event | 2 | 1 | 0.94 |
Operated Valve Endocarditis | 0 | 0 | NS |
Reintervention | 0 | 0 | NS |
Conduction Disturbance | 0 | 0 | NS |
Poor wound healing | 2 | 2 | 1.00 |
Pneumothorax | 3 | 0 | 0.21 |
Subcutaneous emphysema | 2 | 0 | 0.45 |
LVEF (%) | 54.98 ± 7.38 | 56.38 ± 5.22 | 0.16 |
LVED (mm) | 55.76 ± 6.80 | 54.83 ± 6.19 | 0.36 |
ICU stay (days) | 2.10 ± 1.12 | 2.17 ± 0.82 | 0.16 |
Current NYHA (median) | I | I | |
Postoperative hospital stay (days) | 5.17 ± 1.75 | 5.93 ± 1.14 | 0.16 |
Hospital costs (RMB) | 100,980.24 ± 7405.36 | 101,309.91 ± 6911.20 | 0.77 |